Welcome to the ZYLO Blog

Nicotine pouches are transforming adult nicotine use by offering a smoke-free, discreet alternative to traditional cigarettes. Brands like ZYLO provide on-the-go options with no smoke, odor, or tobacco leaf, available in multiple flavors and strengths. These pouches are gaining popularity for convenience, flexibility, and a cleaner nicotine experience, supported by loyalty programs, bundles, and subscription …

Nicotine pouch use in the UK has increased dramatically over the past five years, particularly among young adults aged 16 to 24. Research shows that nearly 700,000 Britons now use nicotine pouches, driven by discreet convenience, flavor variety, and the appeal of a smoke-free experience. Brands like ZYLO are leading the market with high-quality, modern …

Nicotine pouches are rapidly gaining popularity among young men in Great Britain, with usage rates significantly higher than in other demographics. These small, discreet pouches deliver nicotine without tobacco smoke or odor, appealing to users seeking a convenient alternative to traditional smoking. Brands like ZYLO provide a range of flavors and strengths, supporting smoke-free nicotine …

The FDA has authorized six nicotine pouch products under a new streamlined review program, signaling a shift in how smoke-free nicotine alternatives are evaluated in the United States. This decision expands legal market options for adult users, reinforces public health oversight, and highlights growing demand for tobacco-free formats similar to modern brands like ZYLO that …

The Modified Risk Tobacco Product pathway exists to ensure adult smokers receive accurate, science-based information about lower-risk nicotine alternatives. It allows regulators to evaluate whether smoke-free products meaningfully reduce harm compared to cigarettes while safeguarding public health. When properly applied, this pathway supports smoking reduction, informed consumer choice, and responsible innovation across modern nicotine brands …

In 2018, the U.S. Food and Drug Administration reviewed scientific evidence on whether switching completely from cigarettes to smokeless alternatives like snus could lower health risks. The review highlighted reduced exposure to smoke-related harms while maintaining strict regulatory oversight. This evaluation continues to influence how reduced-risk communication is handled and shapes modern smoke-free alternatives such …

The U.S. FDA has authorized several new nicotine pouch products, signaling a shift toward faster regulatory review and wider access to smoke-free alternatives. This decision highlights growing acceptance of nicotine pouches as a lower-risk option compared with combustible tobacco, accelerates product availability for retailers, and reflects rising consumer demand for discreet, tobacco-free nicotine formats. What …